Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered (Record no. 26831960)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02171 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517135057.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201709s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1098-6596 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1128/AAC.02048-16 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Caridha, Diana |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170919 |
245 00 - TITLE STATEMENT | |
Title | Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Antimicrobial agents and chemotherapy |
Date of publication, distribution, etc. | 04 2017 |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amphotericin B |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiprotozoal Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Survival |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Evaluation, Preclinical |
General subdivision | economics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Firefly Luciferin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluconazole |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, Reporter |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | High-Throughput Screening Assays |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leishmania major |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leishmaniasis, Cutaneous |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Luciferases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Luminescent Measurements |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Macrophages |
General subdivision | cytology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Meglumine |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Meglumine Antimoniate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mesocricetus |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred BALB C |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ofloxacin |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Optical Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organisms, Genetically Modified |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organometallic Compounds |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triazoles |
General subdivision | pharmacology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Parriot, Sandi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hudson, Thomas H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lang, Thierry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ngundam, Franklyn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leed, Susan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sena, Jenell |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harris, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | O'Neil, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sciotti, Richard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Read, Lisa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lecoeur, Herve |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hickman, Mark |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grogl, Max |
773 0# - HOST ITEM ENTRY | |
Title | Antimicrobial agents and chemotherapy |
Related parts | vol. 61 |
-- | no. 4 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1128/AAC.02048-16">https://doi.org/10.1128/AAC.02048-16</a> |
Public note | Available from publisher's website |
No items available.